The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Open accessAbstract
CONTEXT: The prevalence of diabetes in the United States has increased. People with diabetes are at risk for diabetic retinopathy. No recent national population-based estimate of the prevalence and severity of diabetic retinopathy exists. OBJECTIVES: To describe the prevalence and risk factors of diabetic retinopathy among US adults with diabetes aged 40 years and older. DESIGN, SETTING, AND PARTICIPANTS: Analysis of a cross-sectional, nationally representative sample of the National Health and Nutrition Examination Survey 2005-2008 (N = 1006). Diabetes was defined as a self-report of a previous diagnosis of the disease (excluding gestational diabetes mellitus) or glycated hemoglobin A(1c) of 6.5% or greater. Two fundus photographs were taken of each eye with a digital nonmydriatic camera and were graded using the Airlie House classification scheme and the Early Treatment Diabetic Retinopathy Study severity scale. Prevalence estimates were weighted to represent the civilian, noninstitutionalized US population aged 40 years and older. MAIN OUTCOME MEASUREMENTS: Diabetic retinopathy and vision-threatening diabetic retinopathy. RESULTS: The estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5% (95% confidence interval [CI], 24.9%-32.5%) and 4.4% (95% CI, 3.5%-5.7%) among US adults with diabetes, respectively. Diabetic retinopathy was slightly more prevalent among men than women with diabetes (31.6%; 95% CI, 26.8%-36.8%; vs 25.7%; 95% CI, 21.7%-30.1%; P = .04). Non-Hispanic black individuals had a higher crude prevalence than non-Hispanic white individuals of diabetic retinopathy (38.8%; 95% CI, 31.9%-46.1%; vs 26.4%; 95% CI, 21.4%-32.2%; P = .01) and vision-threatening diabetic retinopathy (9.3%; 95% CI, 5.9%-14.4%; vs 3.2%; 95% CI, 2.0%-5.1%; P = .01). Male sex was independently associated with the presence of diabetic retinopathy (odds ratio [OR], 2.07; 95% CI, 1.39-3.10), as well as higher hemoglobin A(1c) level (OR, 1.45; 95% CI, 1.20-1.75), longer duration of diabetes (OR, 1.06 per year duration; 95% CI, 1.03-1.10), insulin use (OR, 3.23; 95% CI, 1.99-5.26), and higher systolic blood pressure (OR, 1.03 per mm Hg; 95% CI, 1.02-1.03). CONCLUSION: In a nationally representative sample of US adults with diabetes aged 40 years and older, the prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was high, especially among Non-Hispanic black individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This care gap is a major source of health disparity, with racial and ethnic minorities, and under-resourced communities, having worse outcomes, and a disproportionately higher prevalence of DED2,5–9.”
From Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial (2024) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,909
Self-citationThe Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,482
Self-citationKlein, R., Klein, R., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,382
Self-citationThe Prevalence of Diabetic Retinopathy Among Adults in the United States
Kempen, J. H., O'Colmain, B. J., Leske, M. C., Sm, H., Klein, R., Moss, S. E., Taylor, H. R., & Hamman, R. F. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,168
Self-citationFong, D. S., Aiello, L. P., Gardner, T. W., King, G. L., Blankenship, G. W., Cavallerano, J. D., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s84 · Cited by 1,138
Self-citationStratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
(2001) · Technometrics · doi:10.1198/tech.2001.s612 · Cited by 990
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, A. F. M., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 690
Self-citationPrevalence and Risk Factors for Diabetic Retinopathy
Wong, T. Y., Cheung, N., Tay, W. T., Wang, J. J., Aung, T., Saw, S., Lim, S. C., Tai, E. S., & Mitchell, P. L. R. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.014 · Cited by 428
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Javitt, J. C., & Aiello, L. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00017 · Cited by 411
Harris, M. I., Klein, R., Cowie, C. C., Rowland, M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1230 · Cited by 400
Self-citationSaaddine, J. B. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.12.1740 · Cited by 377
Self-citationDecreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P. H., Tarnow, L., Rossing, K., Rossing, P. R., Eising, S., Larsen, N., Binder, C., & Parving, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 373
Javitt, J. C., Aiello, L. P., Chiang, Y.-P., Ferris, F. L., Canner, J. K., & Greenfield, S. (1994) · Diabetes Care · doi:10.2337/diacare.17.8.909 · Cited by 364
An Alternative Method of Grading Diabetic Retinopathy
Klein, R., Klein, R., Magli, Y. L., Brothers, R. J., Meuer, S. M., Moss, S. E., & Davis, M. D. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33606-6 · Cited by 306
Self-citationVijan, S. (2000) · JAMA · doi:10.1001/jama.283.7.889 · Cited by 295
Diabetic retinopathy and systemic vascular complications
Cheung, N., & Wong, T. Y. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.12.001 · Cited by 280
Wang, C.-Y., Haskell, W. L., Farrell, S. W., LaMonte, M. J., Blair, S. N., Curtin, L., Hughes, J. P., & Burt, V. L. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp412 · Cited by 219
Nordwall, M., Bojestig, M., Arnqvist, H. J., & Ludvigsson, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1431-6 · Cited by 216
Prevalence of diabetic retinopathy in an older community
Mitchell, P., Smith, W., Wang, J. J., & Attebo, K. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)93019-6 · Cited by 204
Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
Hirsch, I. B. (2010) · JAMA · doi:10.1001/jama.2010.785 · Cited by 187
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 158
Self-citationCheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., & Saaddine, J. B. (2009) · Diabetes Care · doi:10.2337/dc09-0440 · Cited by 157
Self-citationLeure‐Dupree, A. E. (1981) · PubMed · Cited by 156
Zhang, X. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.411 · Cited by 135
Self-citationRetinopathy predicts coronary heart disease mortality
Liew, G., Wong, T. Y., Mitchell, P., Cheung, N., & Wang, J. J. (2008) · Heart · doi:10.1136/hrt.2008.146670 · Cited by 114
Nsiah-Kumi, P. A., Ortmeier, S. R., & Brown, A. E. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30929-9 · Cited by 85
Klein, R. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1642 · Cited by 79
Self-citationKlein, R., Lee, K. E., Knudtson, M. D., Gangnon, R. E., & Klein, R. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.012 · Cited by 79
Self-citationMethods of Weighting for Unit Non-Response
Holt, D., & Elliot, D. (1991) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348286 · Cited by 70
Sloan, F. A., Grossman, D. S., & Lee, P. P. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.010 · Cited by 33
A National Progress Report on Diabetes: Successes and Challenges
Geiss, L. S., Engelgau, M. M., POGACH, L. M., Acton, K. J., Fleming, B. B., Roman, S. H., Han, L. F., Wang, J., & Vinicor, F. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.198 · Cited by 30
Self-citationMbadi, A. N. J. N., Longo‐Mbenza, B., Muaka, M. M., Mbungu, F. S., & Lemogoum, D. (2009) · PubMed · Cited by 8
Cited by
Sorted by citations
Gulshan, V., Peng, L., Coram, M., Stumpe, M. C., Wu, D., Narayanaswamy, A., Venugopalan, S., Widner, K., Madams, T., Cuadros, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.17216 · Cited by 7,697
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Self-citationGlobal Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
Teo, Z. L., Tham, Y.-C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., Bikbov, M. M., Wang, Y. X., Tang, Y., Lu, Y., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.04.027 · Cited by 2,420
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
Metadata
- Authors
- Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Zhang, Xinzhi
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-08-11
- Volume
- 304
- Issue
- 6
- Pages
- 649
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC2945293
- OpenAlex
- W2049036672
- Cited by
- 1,196
- References
- 41
- Citations by year
- 2026: 26 · 2025: 62 · 2024: 83 · 2023: 109 · 2022: 82 · 2021: 131 · 2020: 104 · 2019: 91 · 2018: 71 · 2017: 70 · 2016: 66 · 2015: 81 · 2014: 62 · 2013: 65 · 2012: 59
- FWCI
- 55.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 EY999999)
- U.S. Public Health Service (05FED47304)
- National Eye Institute (ZIAEY000402, Z01EY000402)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, prevalence, vision-threatening diabetic retinopathy, diabetes mellitus, risk factors, sex differences, racial disparities, non-Hispanic Black adults, fundus photography, adults aged 40 and older, United States adults
- MeSH terms
- Adult, Aged, Black or African American, Cross-Sectional Studies, Diabetic Retinopathy, Female, Humans, Male, Middle Aged, Nutrition Surveys, Risk Factors, United States, Vision Disorders, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review